Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The effect of the fitness gradient on fixation probability.

Nature communications·2026

Same author

Ambiguity in identifying parameters of an SIR model when fitting epidemic incidence data.

Mathematical biosciences and engineering : MBE·2026

Same author

Neoantigen evolution and response to checkpoint inhibitor immunotherapy in colorectal cancer.

Nature communications·2026

Same author

Mechanistic modeling predicts efficacy of CISH knockout in tumor-infiltrating lymphocytes with synergistic gene editing.

Physical biology·2026

Same author

Mechanistic modeling predicts efficacy of CISH knockout in tumor-infiltrating lymphocytes with synergistic gene editing.

bioRxiv : the preprint server for biology·2025

Same author

Finding Hopf bifurcation islands and identifying thresholds for success or failure in oncolytic viral therapy.

Mathematical biosciences·2024

Search research articles

Related Experiment Video

Updated: Sep 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeting stem cells with oncolytic viruses: a mathematical modelling approach.

Sana Jahedi^1,2, Kamran Kaveh³, James Watmough⁴

¹Department of Mathematics and Statistics, Oakland University, Rochester, MI 48309, USA.

Mathematical Biosciences and Engineering : MBE

|September 3, 2025

Summary

Oncolytic viral therapy targeting cancer stem cells shows promise. Optimal treatment depends on virus infectivity and stem cell specificity, balancing tumor shrinkage with treatment efficacy.

Keywords:

cancer stem cell mathematical model oncolytic virus phenotypic heterogeneity stem cell specificity stem cell targeting treatment strategies virotherapy

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Related Experiment Videos

Last Updated: Sep 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Area of Science:

Oncology
Virology
Mathematical Biology

Background:

Intratumoural epigenetic heterogeneity arises from a stem cell-differentiated cell hierarchy.
Cancer stem cells (CSCs), or tumour-initiating cells, drive tumour growth via self-renewal and differentiation.
Oncolytic viral therapy offers targeted cancer cell destruction with minimal harm to normal cells.

Purpose of the Study:

To investigate the optimal values for virus infectivity and stem cell specificity in oncolytic viral therapy.
To model the interactions within a CSC-differentiated cell hierarchy during oncolytic viral treatment.
To determine conditions for achieving long-term tumour shrinkage.

Main Methods:

Mathematical modeling of cancer stem cell and differentiated cell interactions.
Calculation of the basic reproduction number to constrain infectivity rates.
Analysis of virus infectivity, stem cell specificity, and mitotic rates.

Main Results:

Long-term tumour shrinkage is achievable only when a specific constraint on infectivity rates is met.
Stem cell specificity is influenced by average infectivity and mitotic rates of infected cells.
For nonmitotic cells, high infectivity coupled with high stem cell specificity reduces tumour size; low infectivity favors targeting differentiated cells.

Conclusions:

Oncolytic virus efficacy is highly dependent on the balance between infectivity and targeting specific cell populations (stem vs. differentiated).
The study provides conditions for minimizing tumour size under different infectivity and specificity scenarios.
A perfect stem cell targeting regimen requires specific conditions to achieve maximal tumour reduction.